TradingAgents AISign inGet started
All stock profiles
REPLNASDAQHealthcare

REPLIMUNE GROUP INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$17.61

+1.27%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze REPL free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

+30.9%

3 months

+47.9%

6 months

+604.4%

1 year

+71.8%

Year to date

+81.2%

52-week range

$1.70 – $17.61

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$1.67B

P/E

-6.2

P/B

8.2

P/S

—

Revenue

$0

Net income

-$271.03M

Diluted EPS

-2.79

Gross margin

—

Net margin

—

Return on equity

-157.80%

Total debt

$127.19M

Cash

$309.54M

Free cash flow

-$245.69M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Sep 30, 2026$0-$57.12M——-$47.7M
Jun 30, 2026$0-$69.77M——-$75.73M
Mar 31, 2026$0-$73.22M——-$56.17M
Dec 31, 2025$0-$70.93M——-$66.09M
Sep 30, 2025$0-$83.1M——-$82.56M
Jun 30, 2025$0-$86.69M——-$79.76M
Mar 31, 2025$0-$74.13M——-$54.87M
Dec 31, 2024$0-$66.34M——-$52.51M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent REPL news

All market news

No ticker-linked stories are in the current archive.